InsiderTrades

Form 4 for TECH Bio-Techne

Accepted 2026-05-12 16:04:02 ET · period of report 2026-05-08 · accession 0000914190-26-000092 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2026-05-12 16:04 2026-05-08 TECH Herr Amy E. Dir M - OptEx $47.60 +6,636 6,836 +3,318% +$315.9K
DI 2026-05-12 16:04 2026-05-08 TECH Herr Amy E. Dir S - Sale+OE $48.28 -6,636 200 -97% -$320.4K
DI 2026-05-12 16:04 2026-05-08 TECH Herr Amy E. Dir M - OptEx $0.00 -6,636 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-05-08 M A 6,636 $47.60 6,836 I By significant other — —
2 Common Common Stock 2026-05-08 S D 6,636 $48.28 200 I By significant other — — (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.19 to $48.31, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3 Derivative Stock Option (Right to Buy) 2026-05-08 M D 6,636 $0.00 0 I By significant other $47.60 · — to 2026-08-07 6,636 Common Stock (F3) Fully vested.